Evidence map›Paper›PMID 40377179›Full record

ArticleChemistry, an Asian journal2025

3-Dicyanomethylene-Substituted Thienothiophenes as the Terminal Units in Non-Fullerene Electron Acceptor Molecules for Organic Photovoltaics.

Kensuke Shibahashi, Masato Nakamura, Kohsuke Kawabata, Kazuo Takimiya

Abstract read
In one paragraph

Article in Chemistry, an Asian journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Benzo[1,2-Organic letters · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kensuke Shibahashi *Department of Chemistry, Graduate School of Science, Tohoku University, 6-3 Aoba, Aramaki, Aoba-ku, Sendai, Miyagi, 980-8578, Japan.
Masato Nakamura *Department of Chemistry, Graduate School of Science, Tohoku University, 6-3 Aoba, Aramaki, Aoba-ku, Sendai, Miyagi, 980-8578, Japan.
Kohsuke KawabataDepartment of Chemistry, Graduate School of Science, Tohoku University, 6-3 Aoba, Aramaki, Aoba-ku, Sendai, Miyagi, 980-8578, Japan.ORCID https://orcid.org/0000-0002-8687-0781
Kazuo TakimiyaDepartment of Chemistry, Graduate School of Science, Tohoku University, 6-3 Aoba, Aramaki, Aoba-ku, Sendai, Miyagi, 980-8578, Japan.ORCID https://orcid.org/0000-0002-6001-1129

Funding

Japan Society for the Promotion of Science JP19KK0142Japan Society for the Promotion of Science JP20H05865
6 · The paper itself

Abstract

A series of dicyanomethylene-substituted thieno[3,2-b]- and thieno[2,3-b]-thiophenes and their α-halogenated derivatives (CNTTs) were developed as electron-withdrawing terminal units of non-fullerene acceptors (NFAs) for bulk heterojunction organic photovoltaics (OPVs). The series of CNTTs was combined with a [1,2,5]thiadiazolo[3,4-e]thieno[2'',3'':4',5']thieno[2',3':4,5]pyrrolo[3,2-g]thieno[2',3':4,5]thieno[3,2-b]indole (BTP) unit, the electron-donating core of Y6, a representative NFA, to afford a series of NFAs (BTP-CNTTs). The BTP-CNTTs, particularly the ones with α-chlorinated or brominated CNTT units, exhibit longer absorption wavelengths than that of Y6 and have low-lying LUMO energy levels comparable to that of Y6. Bulk heterojunction OPV devices based on the BTP-CNTTs blended with a representative donor polymer, PBDB-T, exhibited power conversion efficiencies of over 10% under AM1.5 irradiation. These results suggest that the CNTTs are good candidates as electron acceptor building units for NFAs or n-type organic semiconductors.

Indexed as

DicyanomethyleneElectronic structureNear‐infrared absorptionNon‐fullerene acceptorOrganic photovoltaics

Identifiers

PMID40377179
PMCPMC12392713

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.